ON-TARGETplus Human LIN28A (79727) siRNA - SMARTpool

siRNA / miRNA gene silencing Human - hES cell line H1 (WA01) LIN28

Experiment
siRNA / miRNA gene silencing Human - hES cell line H1 (WA01) LIN28
Product
ON-TARGETplus Human LIN28A (79727) siRNA - SMARTpool from Horizon Discovery Ltd.
Manufacturer
Horizon Discovery Ltd.

Protocol tips

Protocol tips
The hESC lines H1 listed in the NIH hESC registry under the names of WA01 respectively) were obtained from WiCell. The iPSC line was generated at the Yale Stem Cell Center using Yamanaka factors (Takahashi et al. 2007). The cells were cultured in an undifferentiated state in Matrigel (BD Pharmingen CA)-coated plates under feeder-free and defined component conditions (Yao et al. 2006) at 37°C in hESC culture incubators (5% CO2, 5% O2, and 90%–95% humidity). Cell growth media were composed of Dulbecco's modified Eagle medium (DMEM)/F12 (Invitrogen), supplemented with 1% MEM-nonessential amino acids (Invitrogen), 1 mM L-glutamine, 1% penicillin-streptomycin (P/S), 50 ng/mL basic fibroblast growth factor (Millipore), N2 supplements (1×), and B27 supplements (1×) (Invitrogen). Cells were maintained with daily medium change and passaged weekly by dissociation into small clumps using 1 mg/mL dispase (StemCell Technology). The hESCs and iPSCs used were between passages 30 and 60 and 10 and 15, respectively. Free of mycoplasma contamination, the cells exhibited normal karyotype, expressed common ES markers, and were able to differentiate into the three germ layers (data not shown). siLin28 (ON-TARGETplus SMARTpool) and siCon were purchased from Dharmacon. To prepare siRNA/lipid solutions for each well of a six-well plate, 9 or 36 pmol of siRNAs were diluted in 50 μL of OPTI-MEMI (Invitrogen) and incubated at room temperature for 5 min. In a separate tube, 5 μL of Lipofectamine 2000 (Invitrogen) was diluted in 50 μL of OPTI-MEMI and incubation carried out for 5 min at room temperature. The contents of the two tubes were combined by gentle pipetting and incubated at room temperature for 30–50 min. The resulting 100 μL of transfection solution was used to resuspend the cell pellet (1 × 106) produced after Accutase dissociation (see above). For siRNA transfection using the standard method, cells were seeded in a 6-well plate 5 d prior to transfection. On the day of transfection, 100 μL of siRNA/lipid solution diluted in 1.5 mL of growth medium was added to each well of cells grown as single-layer colonies attached to the plate. ROCK inhibitors were not involved before, during, or after the transfection. RNAs were extracted for analysis 72 h after the transfection.

Publication protocol

The hESC lines H1 listed in the NIH hESC registry under the names of WA01 respectively) were obtained from WiCell. The iPSC line was generated at the Yale Stem Cell Center using Yamanaka factors (Takahashi et al. 2007). The cells were cultured in an undifferentiated state in Matrigel (BD Pharmingen CA)-coated plates under feeder-free and defined component conditions (Yao et al. 2006) at 37°C in hESC culture incubators (5% CO2, 5% O2, and 90%–95% humidity). Cell growth media were composed of Dulbecco's modified Eagle medium (DMEM)/F12 (Invitrogen), supplemented with 1% MEM-nonessential amino acids (Invitrogen), 1 mM L-glutamine, 1% penicillin-streptomycin (P/S), 50 ng/mL basic fibroblast growth factor (Millipore), N2 supplements (1×), and B27 supplements (1×) (Invitrogen). Cells were maintained with daily medium change and passaged weekly by dissociation into small clumps using 1 mg/mL dispase (StemCell Technology). The hESCs and iPSCs used were between passages 30 and 60 and 10 and 15, respectively. Free of mycoplasma contamination, the cells exhibited normal karyotype, expressed common ES markers, and were able to differentiate into the three germ layers (data not shown). siLin28 (ON-TARGETplus SMARTpool) and siCon were purchased from Dharmacon. To prepare siRNA/lipid solutions for each well of a six-well plate, 9 or 36 pmol of siRNAs were diluted in 50 μL of OPTI-MEMI (Invitrogen) and incubated at room temperature for 5 min. In a separate tube, 5 μL of Lipofectamine 2000 (Invitrogen) was diluted in 50 μL of OPTI-MEMI and incubation carried out for 5 min at room temperature. The contents of the two tubes were combined by gentle pipetting and incubated at room temperature for 30–50 min. The resulting 100 μL of transfection solution was used to resuspend the cell pellet (1 × 106) produced after Accutase dissociation (see above). For siRNA transfection using the standard method, cells were seeded in a 6-well plate 5 d prior to transfection. On the day of transfection, 100 μL of siRNA/lipid solution diluted in 1.5 mL of growth medium was added to each well of cells grown as single-layer colonies attached to the plate. ROCK inhibitors were not involved before, during, or after the transfection. RNAs were extracted for analysis 72 h after the transfection

Full paper   Login or join for free to view the full paper.

Reviews

ON-TARGETplus Human LIN28A (79727) siRNA - SMARTpool from Horizon Discovery Ltd. has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Human - hES cell line H1 (WA01) LIN28 using ON-TARGETplus Human LIN28A (79727) siRNA - SMARTpool from Horizon Discovery Ltd..

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Horizon Discovery Ltd. for ON-TARGETplus Human LIN28A (79727) siRNA - SMARTpool below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - hES cell line H1 (WA01) LIN28 using ON-TARGETplus Human LIN28A (79727) siRNA - SMARTpool from Horizon Discovery Ltd.. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms